These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8093843)

  • 1. The natural history of HIV infection: implications for the assessment of antiretroviral therapy.
    Corey L; Coombs RW
    Clin Infect Dis; 1993 Feb; 16 Suppl 1():S2-6. PubMed ID: 8093843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV immunology and new therapies.
    Kolls JK
    Pediatr Pulmonol Suppl; 2004; 26():59-61. PubMed ID: 15029598
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on drug therapy for HIV and related infections in adults.
    Montauk SL; Mandell K
    Am Fam Physician; 1992 Dec; 46(6):1772-81. PubMed ID: 1360766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moods brighten as statistics lighten.
    Gilden D
    GMHC Treat Issues; 1998 Mar; 12(3):1-5. PubMed ID: 11365390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A changed pattern of opportunistic infections and malignancies in HIV-seropositive patients after the introduction of intensive anti-HIV-combination therapy].
    Borleffs JC; Schneider MM; Hoepelman IM
    Ned Tijdschr Geneeskd; 1998 Oct; 142(44):2395-9. PubMed ID: 9864534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic and viral mechanisms implicated in HIV infection: the impact of treatment].
    Delfraissy JF
    Rev Prat; 1999 Oct; 49(16):1740-5. PubMed ID: 10578603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic indices for the course of HIV infection].
    Hess G
    Verh Dtsch Ges Inn Med; 1991; 97():386-90. PubMed ID: 1687300
    [No Abstract]   [Full Text] [Related]  

  • 8. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
    Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
    AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.
    Osmond D; Charlebois E; Lang W; Shiboski S; Moss A
    JAMA; 1994 Apr; 271(14):1083-7. PubMed ID: 7908703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Asymptomatic patient in human immunodeficiency virus infection].
    Jacomet C; Girard PM
    Rev Prat; 1995 Mar; 45(6):715-21. PubMed ID: 7754309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in HIV/AIDS therapy.
    Johnson SC; Gerber JG
    Adv Intern Med; 2000; 45():1-40. PubMed ID: 10635044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung-specific immune response in tuberculosis.
    Condos R; Rom WN; Weiden M
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S11-7. PubMed ID: 10688143
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous gammaglobulin for pediatric HIV-1 infection. Effects on infectious complications, circulating immune complexes, and CD4 cell decline.
    Rubinstein A; Calvelli T; Rubinstein R
    Ann N Y Acad Sci; 1993 Oct; 693():151-7. PubMed ID: 7903518
    [No Abstract]   [Full Text] [Related]  

  • 14. [Manifestations of immune deficiency in children with perinatal HIV infection in the treatment dynamics].
    Petrova AG; Moskaleva EV; Smirnova SV; Evseeva MG; Shugaeva SN; Romantsov MG
    Antibiot Khimioter; 2011; 56(5-6):54-63. PubMed ID: 22145232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials in HIV infection: current problems and future directions.
    Darbyshire J; Schoenfeld DA; Weller IV
    AIDS; 1991; 5 Suppl 2():S167-73. PubMed ID: 1688258
    [No Abstract]   [Full Text] [Related]  

  • 16. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of opportunistic infections and HIV replication.
    Powderly WG
    AIDS; 1999 Sep; 13(13):1603-6. PubMed ID: 10509559
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children.
    Esposito S; Porta A; Bojanin J; Gualtieri L; Cesati L; Vismara E; Principi N
    Eye (Lond); 2006 May; 20(5):595-7. PubMed ID: 16410815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of opportunistic infections on the frequency of leukocyte subpopulations from type-1 human immunodeficiency virus infected individuals].
    Ramírez Z; Cataño JC; Román A; Rugeles MT; Montoya CJ
    Biomedica; 2008 Mar; 28(1):64-77. PubMed ID: 18645662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.